2ALBRECHT C A, GIESLER G M, KAR B, et al.Intravenous milrinone infusion improves congestive heart failure caused by diastolic dysfunction: a briefcase series[J].Tex Heart Inst J, 2005, 32 (2): 220-223.
3FELKER G M, BENZA R L, CHANDLER A B, et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study [J].J Am Coll Cardiol, 2003, 41 (6) : 997-1003.
4BAYRAM M, DE LUCA L, MASSIE M B, et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes[J].Am J Cardiol, 2005, 96 (6A): 47G-58G.
5SONODA K, IKEDA S, MIYAHARA Y, et al. Successful treatment of chronic pulmonary thromboembolism by long-term intermittent administration of milrinone, a phosphodiesterase inhibitor[J].Intern Med, 2002.41 (11): 961-966.
6LOWES B D, TSVETKOVA T, EICHHORN E J, et al . Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol[J]. Int J Carcliol, 2001, 81 (2-3) : 141-149.
7ARANDA J M, SCHOFIELD R S, PAULY D F. et al. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial [J ]. Am Heart J.2003, 145 (2): 324-329.
8CHANANI N K, COWAN D B, TAKEUCHI K, et al. Milrinone facilitates resuscitation from cardiac arrest and attenuates postresuscltation myocardial dysfunction [J].Circulation, 2003. 108 (24): 3031-3035.
